Merry Christmas to Hemophilia Patients

Gene therapy is a technique that offers the potential to replace defective copies of genes in any genetic disease with an intact version. While the idea of this treatment sounds alluring, the actual practice of it is a whole other story. There are a few drawbacks to this technique that must be considered, including the potential risk of an immune response because the gene is inserted with the use of a virus, which the immune system will see as foreign. Also, most patients so far have needed multiple treatments over the course of their lifetime, estimating to cost much more than anyone can afford. Taking this all into consideration, we can only hope that through collaborations with many researchers that the technique can be refined in the future to prevent such drawbacks and prove to be novel approach to genetic disease.

This has recently been reported for patients with Hemophilia B. Hemophilia B, also known as Christmas disease, is due to a deficiency of the clotting factor IX (FIX). The first reported case of Hemophilia B due to a decrease in FIX was in 1952, and was called “Christmas Disease” after the first patient diagnosed was named Stephen Christmas. Without this clotting factor, the blood does not form clots and results in severe bleeding episodes, especially in the joints and muscles.

Bettert reatment for this disorder began back in the 1960’s where they would inject FIX concentrates into the blood of patients with hemophilia B. This increased the average age of death of 24 to a median lifespan of 63 years of age. So with the success of the protein therapy, why try to fix the genes? With each treatment costing $150,000 to $300,000, a patient needing clotting factors for hemophilia could incur a lifetime cost of $20 million.

So there needs to be a way that a patient can have a more effective treatment option that will cost less. This new treatment option offers some hope. Using a new virus for the administration of the gene, patients have seen an increased production of FIX protein for longer periods of time, and were able to stop or decrease the amount of concentrate injections they would need. With one injection of the virus only costing about $30,000, dramatic cost savings have already been seen. While this does offer new hope for the treatment of clotting disorders, follow-up with a larger number of patients and for longer periods of time will be needed to fully weigh the benefits and risks of this technique. Once this has been done, hopefully we will see gene therapy used more in practice and maybe even for more than just clotting disorders.

No trackbacks yet.

Alzheimer’s disease (AD) steals memories and disrupts lives of 5.4 million Americans (according to Alzheimer’s Foundation statistics) and 26.6 million people worldwide. Moreover AD is predicted to affect 1 in 85 people globally by 2050! AD still cannot be cured and is degenerative, so the sufferer relies on others for assistance, placing a great…

For the last decade or so, progressive cancer treatments involved taking samples of tumors, testing the cells to determine the genetic makeup, and then prescribing medicines targeted to specific mutations. There are many benefits to this approach, but it doesn’t always work. It turns out that tumors aren’t uniform; they are mosaics of cells that…

A cheap drug called Minocycline, which is normally prescribed for pneumonia and acne will be tested in a new trial to reduce the symptoms of psychosis in patients suffering from schizophrenia. Schizophrenia is a mental disorder characterized by a breakdown of thought processes and by poor emotional responsiveness. According to the WHO the disorder affects…

For a very long time I have been using Diabetes as an example of a disorder that is caused by a mutation in the insulin gene. This mutation would stop the cells from making insulin, and a diabetic might need daily insulin injections to regulate their sugar levels properly. I don’t know what took me…

After asking students during a lesson on mutations if it is possible that a mutation in DNA could be good, most students will nod yes without much understanding. Recently, I finally had one student raise his hand immediately and answer the question (with extreme surprise that no other students were blurting out the answer)…”evolution!” He…

This article in science is good news for suffers of Alzheimer’s. A group out of Case Western University reports that the drug Bexarotene can reverse the symptoms of Alzheimer’s in mouse models of the disease. More importantly, Bexarotene is already in use in human patients, making it easier to determine if the drug will have…

Classic genetics alone is unable to explain the diversity we see within a population of living things. This also cannot explain how identical twins with the same DNA sequences can have differences in their traits and development of disease. First introduced in 1939 by C.H. Waddington, epigenetics is now able to offer some explanation, as…

One of the biggest challenges facing cancer researchers is that the disease varies so much from person to person. Even the same type of cancer – lung, brain, breast, colon, and so on – can be subtly different. This means that a therapy that works well in one patient may have no effect in another.…

When we think of a detective the first thing that comes to mind is an investigator, either a member of a police agency or a private entity. However there are unique detectives within the multifaceted arena of medicine. All though we might already think of most doctors as detectives there are special doctors, units, working at…

Autumn is my favorite season. I enjoy the cool weather, unpacking my sweaters from the attic and sleeping under my cozy comforter. But better than all of the above are the fantastic red, yellow and orange leaves that adorn the deciduous trees here in New York. Before I worked at the DNA Learning Center, this…